This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Orel, S. Search for Related Content PubMed PubMed Citation Articles by Orel, S. Social Bookmarking                            What's this?

Who Should Have Breast Magnetic Resonance Imaging Evaluation?

Susan Orel

From the Department of Radiology/Breast Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA

Corresponding author: Susan Orel, MD, Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104; e-mail: Susan.Orel{at}uphs.upenn.edu

During the last two decades, tremendous advances have been made in the performance and interpretation of breast magnetic resonance imaging (MRI) examinations. Technical requirements for optimal breast imaging including the requirement for a breast MRI biopsy system are now being defined as part of a voluntary American College of Radiology (ACR) breast MRI accreditation program. The ACR BI-RADS (Breast Imaging Reporting and Data System) lexicon for breast MRI has brought uniformity to the interpretation of breast MRI examinations. With these advances in imaging technique, interpretation guidelines, and increasing availability of MR-compatible breast biopsy systems, MRI of the breast is rapidly gaining popularity in clinical practice in both the diagnostic setting and, more recently, in the screening setting. The clinical indications for breast MRI, however, remain to be defined. There are clinical indications that have emerged where MRI, as an adjunct to mammography, seems to be the imaging study of choice. There are other indications, specifically breast cancer staging, in which MRI is being utilized with increasing frequency, but in which controversy persists.

Author's disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. L. Arenson Recommendations for Additional Imaging in Radiology Reports: Radiologists' Self-Referral or Good Clinical Practice? Radiology, November 1, 2009; 253(2): 291 - 292. [Full Text] [PDF]

				M. CHELLMAN-JEFFERS IN REPLY: Cleveland Clinic Journal of Medicine, July 1, 2009; 76(7): 385 - 389. [Full Text] [PDF]

				H.-G. Moon, W. Han, J. W. Lee, E. Ko, E.-K. Kim, J.-H. Yu, S. Y. Kang, W. K. Moon, N. Cho, I.-A. Park, et al. Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment Ann. Onc., April 1, 2009; 20(4): 636 - 641. [Abstract] [Full Text] [PDF]